Filter News
Area of Research
- (-) Advanced Manufacturing (2)
- (-) National Security (5)
- (-) Neutron Science (30)
- Biological Systems (1)
- Biology and Environment (4)
- Clean Energy (20)
- Computer Science (1)
- Materials (16)
- Materials for Computing (1)
- Nuclear Science and Technology (2)
- Quantum information Science (2)
- Supercomputing (14)
News Type
News Topics
- (-) Bioenergy (5)
- (-) Cybersecurity (4)
- (-) Neutron Science (30)
- 3-D Printing/Advanced Manufacturing (8)
- Artificial Intelligence (4)
- Big Data (2)
- Biology (1)
- Biomedical (6)
- Clean Water (1)
- Climate Change (1)
- Computer Science (13)
- Coronavirus (5)
- Energy Storage (2)
- Environment (5)
- Machine Learning (5)
- Materials (1)
- Materials Science (10)
- Mathematics (1)
- Microscopy (1)
- Nanotechnology (5)
- National Security (3)
- Nuclear Energy (3)
- Physics (3)
- Polymers (1)
- Quantum Science (2)
- Security (4)
- Summit (5)
- Sustainable Energy (2)
- Transformational Challenge Reactor (1)
- Transportation (1)
Media Contacts
An ORNL-led team's observation of certain crystalline ice phases challenges accepted theories about super-cooled water and non-crystalline ice. Their findings, reported in the journal Nature, will also lead to better understanding of ice and its various phases found on other planets, moons and elsewhere in space.
Tempering, the heating process that gives chocolate its appealing sheen and creamy texture, is a crucial part of crafting quality chocolate. But, at the molecular level, it gets a little tricky, and when done incorrectly, can render entire batches of chocolate gritty and unappetizing.
OAK RIDGE, Tenn., May 14, 2019—Advanced Research Systems, Inc., has licensed a technology designed to automatically refill liquid helium used in laboratory equipment for low-temperature scientific experiments, which will reduce downtime, recover more helium and increase overall efficiency.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.